SCHEMBL5136440

SCHEMBL5136440

O=C(CCCCCCCCC(O)CO)OCCO

nearest known ligand 0.51

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
KDM4E B2RXH2 1/20 0.51
DUSP3 P51452 1/20 0.51
MEN1 O00255 1/20 0.51
KMT2A Q03164 1/20 0.51
LMNA P02545 1/20 0.51
L3MBTL1 Q9Y468 2/20 0.46
ALDH1A1 P00352 1/20 0.46
DGKA P23743 2/20 0.44
MGLL Q99685 1/20 0.40
MAPT P10636 1/20 0.39
CNR2 P34972 2/20 0.38
PRKCA P17252 1/20 0.38
PRKCE Q02156 1/20 0.38
PRKCQ Q04759 1/20 0.38
PRKCD Q05655 1/20 0.38
PTPN1 P18031 1/20 0.38
DNM1 Q05193 1/20 0.38
FFAR4 Q5NUL3 1/20 0.37
FFAR1 O14842 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2143293 0.91 DGKA (0.58) KDM4EDUSP3MEN1KMT2ALMNA
SCHEMBL28104644 0.86 KDM4E (0.70) KDM4EDUSP3MEN1KMT2ALMNA
SCHEMBL29193301 0.85 DGKA (0.53) KDM4EDUSP3MEN1KMT2ALMNA
SCHEMBL7561059 0.85 DGKA (0.53) KDM4EDUSP3MEN1KMT2ALMNA
SCHEMBL29193381 0.85 DGKA (0.62) KDM4EDUSP3MEN1KMT2ALMNA
SCHEMBL29110916 0.85 FFAR4 (0.49) KDM4EDUSP3MEN1KMT2ALMNA
SCHEMBL727225 0.85 DGKA (0.53) KDM4EDUSP3MEN1KMT2ALMNA
SCHEMBL505106 0.85 DGKA (0.62) KDM4EDUSP3MEN1KMT2ALMNA
SCHEMBL6052685 0.85 DGKA (0.62) KDM4EDUSP3MEN1KMT2ALMNA
SCHEMBL16800412 0.85 DGKA (0.62) KDM4EDUSP3MEN1KMT2ALMNA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 30 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-115869271-A 3D printing glue composition 大连五音方科技有限公司 2023-03-31 CN claimed
CN-111107841-B Method for preparing solid dosage forms comprising antibodies by wet granulation, extrusion and spheronization 蒂洛特斯制药股份有限公司 2023-03-10 CN claimed
EP-1315500-A4 PHARMACEUTICAL COMPOSITIONS FOR TOPICAL DELIVERY OF CYCLOOXYGENASE-2 ENZYME INHIBITORS RANBAXY LAB LTD (IN) 2006-05-31 EP claimed
WO-2005044227-A1 TOPICAL PHARMACEUTICAL COMPOSITIONS GLENMARK PHARMACEUTICALS LIMITED (US) 2005-05-19 WO claimed
US-20050096371-A1 Topical pharmaceutical compositions GLENMARK PHARMACEUTICALS LIMITED (IN) 2005-05-05 US claimed
US-20050049291-A1 Process for the preparation of pharmaceutical compositions for topical delivery of cyclooxygenase-2-enzyme inhibitors RANBAXY LABORATORIES LIMITED (IN) 2005-03-03 US claimed
EP-1448209-A2 A PROCESS FOR THE PREPARATION OF PHARMACEUTICAL COMPOSITIONS FOR TOPICAL DELIVERY OF CYCLOOXYGENASE-2 ENZYME INHIBITORS RANBAXY LABORATORIES, LTD. (IN) 2004-08-25 EP claimed
US-20040029946-A1 Pharmaceutical compositions for topical delivery of cyclooxygenase-2 enzyme inhibitors RANBAXY LABORATORIES LIMITED (IN) 2004-02-12 US claimed
EP-1315500-A1 PHARMACEUTICAL COMPOSITIONS FOR TOPICAL DELIVERY OF CYCLOOXYGENASE-2 ENZYME INHIBITORS Ranbaxy Laboratories, Limited (IN) 2003-06-04 EP claimed
WO-2003035080-A2 A PROCESS FOR THE PREPARATION OF PHARMACEUTICAL COMPOSITIONS FOR TOPICAL DELIVERY OF CYCLOOXYGENASE-2 ENZYME INHIBITORS RANBAXY LABORATORIES LIMITED (IN) 2003-05-01 WO claimed
WO-2002017923-A1 PHARMACEUTICAL COMPOSITIONS FOR TOPICAL DELIVERY OF CYCLOOXYGENASE-2 ENZYME INHIBITORS RANBAXY LABORATORIES LIMITED (IN) 2002-03-07 WO claimed
CN-115869271-A 3D printing glue composition 大连五音方科技有限公司 2023-03-31 CN disclosed
CN-110123749-B Nicorandil lipid microsphere preparation and preparation method thereof 太阳升(亳州)生物医药科技有限公司 2022-01-25 CN disclosed
CN-109260030-B Micelle composition and preparation method and application thereof 昌正医疗(苏州)有限公司 2021-11-02 CN disclosed
US-10328154-B2 Topical compositions for improved delivery of active agents BUFFERAD Illinois Inc. (US) 2019-06-25 US disclosed
EP-1448209-A2 A PROCESS FOR THE PREPARATION OF PHARMACEUTICAL COMPOSITIONS FOR TOPICAL DELIVERY OF CYCLOOXYGENASE-2 ENZYME INHIBITORS RANBAXY LABORATORIES, LTD. (IN) 2004-08-25 EP disclosed
US-20040029946-A1 Pharmaceutical compositions for topical delivery of cyclooxygenase-2 enzyme inhibitors RANBAXY LABORATORIES LIMITED (IN) 2004-02-12 US disclosed
EP-1315500-A1 PHARMACEUTICAL COMPOSITIONS FOR TOPICAL DELIVERY OF CYCLOOXYGENASE-2 ENZYME INHIBITORS Ranbaxy Laboratories, Limited (IN) 2003-06-04 EP disclosed
WO-2003035080-A2 A PROCESS FOR THE PREPARATION OF PHARMACEUTICAL COMPOSITIONS FOR TOPICAL DELIVERY OF CYCLOOXYGENASE-2 ENZYME INHIBITORS RANBAXY LABORATORIES LIMITED (IN) 2003-05-01 WO disclosed
WO-2002017923-A1 PHARMACEUTICAL COMPOSITIONS FOR TOPICAL DELIVERY OF CYCLOOXYGENASE-2 ENZYME INHIBITORS RANBAXY LABORATORIES LIMITED (IN) 2002-03-07 WO disclosed